AU2013351152A1 - Crystallization process of tricyclic indole derivatives - Google Patents

Crystallization process of tricyclic indole derivatives Download PDF

Info

Publication number
AU2013351152A1
AU2013351152A1 AU2013351152A AU2013351152A AU2013351152A1 AU 2013351152 A1 AU2013351152 A1 AU 2013351152A1 AU 2013351152 A AU2013351152 A AU 2013351152A AU 2013351152 A AU2013351152 A AU 2013351152A AU 2013351152 A1 AU2013351152 A1 AU 2013351152A1
Authority
AU
Australia
Prior art keywords
composition
compound
formula
fluoro
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013351152A
Other languages
English (en)
Inventor
Srinath Balaji Aralikatti Prahladachar Balaji
Afsal Mohammed Kadavilpparampu Mohamed
Umamaheshwar P. MOKKAPATI
Sondre NILSEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1300647.3A external-priority patent/GB201300647D0/en
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Publication of AU2013351152A1 publication Critical patent/AU2013351152A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
AU2013351152A 2012-11-30 2013-11-28 Crystallization process of tricyclic indole derivatives Abandoned AU2013351152A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN3689/DEL/2012 2012-11-30
IN3689DE2012 2012-11-30
GB1300647.3 2013-01-15
GBGB1300647.3A GB201300647D0 (en) 2013-01-15 2013-01-15 Crystallization
PCT/EP2013/074986 WO2014083113A1 (en) 2012-11-30 2013-11-28 Crystallization process of tricyclic indole derivatives

Publications (1)

Publication Number Publication Date
AU2013351152A1 true AU2013351152A1 (en) 2015-05-21

Family

ID=54266915

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013351152A Abandoned AU2013351152A1 (en) 2012-11-30 2013-11-28 Crystallization process of tricyclic indole derivatives

Country Status (12)

Country Link
US (1) US10709798B2 (enExample)
EP (1) EP2943195A1 (enExample)
JP (1) JP6280560B2 (enExample)
KR (1) KR20150088802A (enExample)
CN (2) CN104837489A (enExample)
AU (1) AU2013351152A1 (enExample)
BR (1) BR112015012138A2 (enExample)
CA (1) CA2892485A1 (enExample)
IN (1) IN2015DN03978A (enExample)
MX (1) MX2015006871A (enExample)
RU (1) RU2015118217A (enExample)
WO (1) WO2014083113A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015118217A (ru) 2012-11-30 2017-01-11 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ кристаллизации трициклических индольных производных
US20160144477A1 (en) * 2014-11-21 2016-05-26 Diane Scott Coated compressive subpad for chemical mechanical polishing

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177440B1 (en) * 1996-10-30 2001-01-23 Eli Lilly And Company Substituted tricyclics
CA2310250A1 (en) 1997-11-14 1999-05-27 August Masaru Watanabe Treatment for alzheimer's disease
DZ2769A1 (fr) 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
JP2005527466A (ja) 2001-08-09 2005-09-15 イーライ・リリー・アンド・カンパニー ｓＰＬＡ２インヒビターとしてのシクロヘプトＢインドール誘導体
WO2003014082A1 (en) 2001-08-09 2003-02-20 Eli Lilly And Company Cyclopenta ` b ! indole derivatives as spla2 inhibitors
GB0905328D0 (en) * 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives
SG183837A1 (en) * 2010-03-26 2012-10-30 Ge Healthcare Ltd Tricyclic indole derivatives as pbr ligands
GB201016038D0 (en) 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
GB201016411D0 (en) * 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
GB201021263D0 (en) 2010-12-15 2011-01-26 Ge Healthcare Ltd Solid phase extraction method
US9220795B2 (en) * 2011-09-22 2015-12-29 Ge Healthcare Limited Indole derivatives
RU2015118217A (ru) 2012-11-30 2017-01-11 ДжиИ ХЕЛТКЕР ЛИМИТЕД Способ кристаллизации трициклических индольных производных

Also Published As

Publication number Publication date
BR112015012138A2 (pt) 2017-07-11
WO2014083113A1 (en) 2014-06-05
KR20150088802A (ko) 2015-08-03
EP2943195A1 (en) 2015-11-18
RU2015118217A (ru) 2017-01-11
CN111362863A (zh) 2020-07-03
CA2892485A1 (en) 2014-06-05
US20150335766A1 (en) 2015-11-26
MX2015006871A (es) 2015-09-16
CN104837489A (zh) 2015-08-12
US10709798B2 (en) 2020-07-14
IN2015DN03978A (enExample) 2015-10-02
JP2016507477A (ja) 2016-03-10
JP6280560B2 (ja) 2018-02-14

Similar Documents

Publication Publication Date Title
JP6216421B2 (ja) 造影剤の合成および使用のための組成物、方法およびシステム
ES3023366T3 (en) Heteroalkyl dihydroquinoline sulfonamide compounds
JP6964450B2 (ja) 造影剤の合成および使用のための組成物、方法およびシステム
RU2468014C2 (ru) Фторсодержащие лиганды для нацеливания периферических бензодиазепиновых рецепторов
US20240217974A1 (en) Isoquinolone compound and use thereof
JP5322180B2 (ja) フッ素およびヒドロキシ基で置換されたアルコキシ基を有するｐｅｔプローブ
UA114295C2 (uk) Сполука бензотіазолону
AU2013351152A1 (en) Crystallization process of tricyclic indole derivatives
JP5870031B2 (ja) 自動化放射合成
CN108884099A (zh) 一种咪唑并异吲哚类衍生物的游离碱的结晶形式及其制备方法
CN111867577A (zh) 依克立达的氘化类似物
US12522579B2 (en) Monoamine oxidase B imaging probe
WO2013014274A1 (en) 5ht1a antagonist useful for in vivo imaging
US20230158178A1 (en) Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof
WO2024263515A2 (en) Stearoyl coa desaturase 1 (scd1) radiotracers
EA025823B1 (ru) Способ получения f-18 меченых лигандов бета-амилоида
HK1241356A1 (en) Compositions, methods and systems for the synthesis and use of imaging agents
HK1241356B (zh) 用於合成和使用造影剂的组合物、方法和系统
HK1182933A (en) Compositions, methods and systems for the synthesis and use of imaging agents

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period